With the FDA announcing it will approve an anti-inflammatory drug that blocks the brain’s natural production of cortisol, the question becomes: when can you get your hands on it?
The drugs, called benzodiazepines, have been used for years as part of the standard care of the elderly and in the treatment of some form of anxiety disorder.
The FDA has long said the benzodiazapine, which is sold under the brand name Cephalosporin, can be taken safely.
But for some patients, the drugs may become a danger.
They may cause a seizure or even become dangerously unstable and need to be controlled with sedatives or a sleep aid.
Some are already using benzodilators to treat depression, and in April, the FDA approved a drug to treat PTSD in a similar way.
The benzodazole is one of a handful of drugs on the market that can treat depression and anxiety, said Sarah Pfeifer, a senior adviser at the Kaiser Family Foundation, a public health think tank in California.
Pfeiber said her group recommends that patients who have not had benzodolazine therapy for anxiety and depression try it, even if they are already prescribed a benzodox or other medication.
She said the drugs could be used to treat those with mild or moderate symptoms, but added that those who are suffering from severe or severe anxiety or depression should get their medication off the market and have a doctor look at their symptoms.
“We have a responsibility to people who have mental health issues to have the medication off their hands,” she said.
“But when you are taking benzodrazole, do not use it alone, use it with the person that you are trying to treat.”
Pfeifer said it was important to keep in mind the potential side effects of benzodizapine.
Benzodiazepine has been linked to cardiac problems and strokes.
And benzodimazolone, which works on serotonin receptors, can cause anxiety and insomnia.
“It is a medication that can be used safely, and it has to be used with care,” she added.
The FDA says it will not comment on specific drug approval applications.